Literature DB >> 31259763

Coronary atherosclerosis characteristics in HIV-infected patients on long-term antiretroviral therapy: insights from coronary computed tomography-angiography.

Thomas Senoner1, Fabian Barbieri1, Agne Adukauskaite1, Mario Sarcletti2, Fabian Plank1, Christoph Beyer3, Wolfgang Dichtl1, Gudrun M Feuchtner3.   

Abstract

OBJECTIVE: The aim of the study was to assess coronary artery disease (CAD) characteristics by coronary computed tomography-angiography (CCTA) in individuals with HIV infection on long-term antiretroviral therapy (ART)
DESIGN: : Retrospective case-controlled matched cohort study.
METHODS: Sixty-nine HIV-positive patients who underwent 128-slice dual source CCTA (mean age 54.9 years, 26.1% women) with mean 17.8 ± 9.4 years of HIV infection and a mean duration on ART of 13 ± 7.3 years were propensity score-matched (1 : 1) for age, sex, BMI, and five cardiovascular risk factors with 69 controls. CCTA was evaluated for stenosis severity [according to Coronary Artery Disease - Reporting and Data System (CAD-RADS)], total plaque burden [segment involvement score (SIS) and mixed-noncalcified plaque burden (G-score)]. As inflammatory biomarkers, high-risk plaque (HRP) features (napkin-ring sign, low-attenuation plaque, spotty calcification, positive remodeling), perivascular fat attenuation index (FAI), and ectatic coronary arteries were assessed.
RESULTS: CAD-RADS was higher in HIV-positive participants as compared with controls (2.21 ± 1.4 vs. 1.69 ± 1.5, P = 0.031). A higher prevalence of CAD and G-score (P = 0.043 and P = 0.003) was found. HRP prevalence [23 (34.3%) vs. 8 (12.1%); P = 0.002] and the number of HRP (36 vs. 10, P < 0.001) were higher in HIV-positive individuals. A perivascular FAI greater than -70 Hounsfield units was present in 27.8% of HRP. Ectatic coronary arteries were found in 10 (14.5%) HIV-positive persons vs. 0% in controls (P = 0.003).
CONCLUSION: Noncalcified and HRP burden in HIV-infected individuals on long-term ART is higher and associated with higher cardiovascular risk. Moreover, HIV-positive individuals displayed a higher stenosis severity (CAD-RADS) and more ectatic coronary arteries compared with the control group.

Entities:  

Year:  2019        PMID: 31259763     DOI: 10.1097/QAD.0000000000002297

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection.

Authors:  Jean Jeudy; Pratik Patel; Nivya George; Shana Burrowes; Jennifer Husson; Joel Chua; Lora Conn; Robert G Weiss; Shashwatee Bagchi
Journal:  AIDS       Date:  2022-03-01       Impact factor: 4.177

2.  Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.

Authors:  Jonathan A Hudson; Edith D Majonga; Rashida A Ferrand; Pablo Perel; Shirjel R Alam; Anoop S V Shah
Journal:  JAMA       Date:  2022-09-13       Impact factor: 157.335

3.  Association of epicardial fat with noncalcified coronary plaque volume and with low attenuation plaque in people with HIV.

Authors:  Manel Sadouni; Madeleine Durand; Irina Boldeanu; Coraline Danieli; Paule Bodson-Clermont; Samer Mansour; Jean-Guy Baril; Benoit Trottier; Cécile Tremblay; Carl Chartrand-Lefebvre
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.632

4.  Sex modifies the association between HIV and coronary artery disease among older adults in Uganda.

Authors:  Chris T Longenecker; Milana Bogorodskaya; Seunghee Margevicius; Rashidah Nazzinda; Marcio Sommer Bittencourt; Geoffrey Erem; Sophie Nalukwago; Moises A Huaman; Brian B Ghoshhajra; Mark J Siedner; Steven M Juchnowski; David A Zidar; Grace A McComsey; Cissy Kityo
Journal:  J Int AIDS Soc       Date:  2022-01       Impact factor: 5.396

5.  Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and Meta-Analysis.

Authors:  Cullen Soares; Amjad Samara; Matthew F Yuyun; Justin B Echouffo-Tcheugui; Ahmad Masri; Ahmad Samara; Alan R Morrison; Nina Lin; Wen-Chih Wu; Sebhat Erqou
Journal:  J Am Heart Assoc       Date:  2021-09-29       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.